1st Quarter - Report

WALGREEN COMPANY for WALGREEN COMPANY

Firm
Client
Income
—
Expenses
$770,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

H.R. 3179 - the "Market Place Equity Act of 2011," all provisions regarding authorizing states to require all sellers making remote sales to collect and remit sales and use taxes with respect to such sales into the state, without regard to the location of the seller. S. 1832 - the "Marketplace Fairness Act," all provisions regarding authorizing member states under the Streamlined Sales and Use Tax Agreement to require all sellers (minus small seller exception) to collect and remit sales and use taxes with respect to remote sales and allowing a state that is not a member state under the Agreement to require sellers to collect and remit sales and use taxes without respect to remote sales.

LobbyistCovered position, as disclosed
DEBBIE GARZA —
ALETHIA JACKSON —
EDWARD KALETA —
HEATHER HERNDON SMITH —

Contacted: Federal Trade Commission (FTC); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP)

Bills named: S. 1832 (112th), H.R. 3179 (112th)

Health Issues HCR

H.R. 2529/S.1368 - the "Restoring Access to Medication Act," all provisions regarding repealing provisions of the Patient Protection and Affordable Care Act that limits payments for medications from health savings accounts, medical savings accounts, and health felxible spending arrangements to only prescriotion drugs or insulin.

LobbyistCovered position, as disclosed
DEBBIE GARZA —
ALETHIA JACKSON —
EDWARD KALETA —
HEATHER HERNDON SMITH —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Federal Trade Commission (FTC); Executive Office of the President (EOP); SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 2529 (112th), S. 1368 (112th)

Medicare/Medicaid MMM

S. 274 - the "Medication Therapy Management Empowerment Act of 2011," all provisions regarding amending the Medicare Modernization Act to expand the eligibility of all targeted beneficiaries for access to Medication Therapy Management (MTM) in Medicare Part D. H.R. 891 - the "Medication Therapy Management (MTM) Benefits Act of 2011," all provisions related to the requirement of MTM services to include person-to-person targeted medication reviews by a licensed pharmacist offered at least every quarter and expand eligibility of all target beneficiaries for access to MTM. H.R. 1936 - the "Medicare Access to Diabetes Supplies Act of 2011," provisions related to the exemption from Medicare competitive acquisition programs of blood glucose self-testing equipment and supplies furnished by small retail community pharmacies. H.R. 2195/S. 1203 - the "Medicare Home Infusion Therapy Coverage Act," provisions related to the Medicare coverage of home infusion therapy and home infusion drugs. H.R. 3342/S. 1356 - the "Affordable Medicines Utilization Act of 2011," all provisions regarding requiring an increase in the quarterly Medicaid payment to a state by 50% of the generic drug utilization savings amount if the state's generic substitution rate for the most recent preceding fiscal year for which data is available is greater than its rate for the most recent second preceding fiscal year for which data is available. P.L. 111-148 - the "Patient Protection and Affordable Care Act," all provisions regarding the implementation of regulations of P.L. 111-148, including issues related to Average Manufacturer's Price (AMP), Medication Therapy Management (MTM), employer coverage mandates, pilot programs and demonstration projects.

LobbyistCovered position, as disclosed
DEBBIE GARZA —
ALETHIA JACKSON —
EDWARD KALETA —
HEATHER HERNDON SMITH —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Executive Office of the President (EOP); Federal Trade Commission (FTC)

Bills named: S. 1203 (112th), H.R. 3342 (112th), H.R. 1936 (112th), S. 1356 (112th), H.R. 891 (112th), H.R. 2195 (112th), S. 274 (112th)

Consumer Issues/Safety/Products CSP

No Legislation: Consumer protection advocacy in opposition to the merger of Express Scripts, Inc. and Medco Health Solutions, Inc.

LobbyistCovered position, as disclosed
DEBBIE GARZA —
ALETHIA JACKSON —
EDWARD KALETA —
HEATHER HERNDON SMITH —

Contacted: Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); SENATE; Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES

Pharmacy PHA

H.R. 4215 - the "Medicare Pharmacy Transparency and Fair Auditing Act," all provisions regarding requiring each contract entered into with a prescripotion drug plan (PDP) sponsor for the offering of a prescription drug plan to prohibit PDP sponsor from contracting with any pharmacy benefits manager (PBM) to manage the prescription drug coverage under each plan. H.R. 1971/S. 1058 - the "Pharmacy Competition and Consumer Choice Act of 2011," all provisions related to requirement of Pharmacy Benefit Managers annually reporting to Part D plan sponsors number and total cost of prescriptions under a contract, payments to pharmacies, payments from pharmaceuticals manufacturers and generic and brand name drugs dispensed. H.R. 3026 - the "Safeguarding America's Pharmaceutical Act," all provisions; Requires the Secretary of Health and Human Services (HHS) to issue regulations to establish an effective drug identification and tracking system through which drug manufacturers, repackagers, wholesale distributors, and dispensers may authenticate the wholesale distribution history of any prescription drug that is subject to a requirement for a standardized numerical identifier. S. 1584 - the "Drug Safety and Accountability Act," all provisions; Authorizes the Secretary of Health and Human Services (HHS) to order an establishment to promptly revise its quality management plan in response to a significant threat to public health and requires each registered drug producer to report on each producer, manufacturer, distributor, and shipper involved in the production of a drug or the production or transport of the active ingredients of a drug. Requires the Secretary to develop and maintain information systems to track and assess every establishment that is involved in the manufacturing, preparation, propagation, compounding, or processing of a drug or active ingredient of a drug. H.R. 4095 - the "Online Pharmacy Safety Act," all provisions regarding requiring the U.S. Department of Health and Human Services (HHS) to create a public registry of legitimate online pharmacy websites.

LobbyistCovered position, as disclosed
DEBBIE GARZA —
ALETHIA JACKSON —
EDWARD KALETA —
HEATHER HERNDON SMITH —

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 1971 (112th), H.R. 4095 (112th), H.R. 3026 (112th), S. 1584 (112th), S. 1058 (112th), H.R. 4215 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.